Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DermTech Inc DMTKQ

Healthcare Biotechnology
DermTech, Inc. has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.


GREY:DMTKQ - Post by User

DermTech Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Post by Redrum180on Jul 07, 2021 3:50pm
237 Views
Post# 33506678

DermTech Management Query

DermTech Management Query     A company called Medx on the Venture Exchage claims to have a cheap and effective way of diagnosing skin lesions and detecting melanomas, yet their share price languishes at about .12 CAD and trades in very light volume.

     Why wouldn't DermTech at least investigate the possibility of acquiring this company.  

     Their website is medxhealth.com.  If someone is in touch with their management, could they run this by them and possibly provide an answer on this board?

     Full disclosure:   I am long a modest 15,000 shares of Medx, a tiny percentage of my portfolio.  

     Thanks in advance for any information you can provide.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities